Evidence map›Paper›PMID 36989915›Full record

ArticleHealthcare (Amsterdam, Netherlands)2023

Implementing real-time prescription benefit tools: Early experiences from 5 academic medical centers.

Jing Luo, Rachel Wong, Tanvi Mehta, Jeremy I Schwartz, Jeremy A Epstein, Erika Smith, Nitu Kashyap, Fasika A Woreta, Kristian Feterik, Michael J Fliotsos and 1 more

Abstract read
In one paragraph

Article in Healthcare (Amsterdam, Netherlands), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Price transparency at the point of prescribing with real-time prescription benefits.American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists · 2024
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jing LuoDivision of General Internal Medicine, University of Pittsburgh School of Medicine, USA. Electronic address: luoj@pitt.edu.
Rachel WongDepartment of Biomedical Informatics, Renaissance School of Medicine at Stony Brook, USA.
Tanvi MehtaDuke University School of Medicine, USA.
Jeremy I SchwartzSection of General Internal Medicine Yale University School of Medicine, USA.
Jeremy A EpsteinDivision of General Internal Medicine, Johns Hopkins University School of Medicine, USA.
Erika SmithFroedtert & Medical College of Wisconsin, USA.
Nitu KashyapYale New Haven Health and Yale School of Medicine, USA.
Fasika A WoretaWilmer Eye Institute, Johns Hopkins Hospital, USA.
Kristian FeterikDivision of General Internal Medicine, University of Pittsburgh School of Medicine, USA.
Michael J FliotsosWilmer Eye Institute, Johns Hopkins Hospital, USA; Yale New Haven Hospital, Department of Ophthalmology and Visual Sciences, New Haven, CT, USA.
Bradley H CrottyFroedtert & Medical College of Wisconsin, USA.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Institutional Career Development CoreKL2TR001856 · NCATS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI RAY, KRISTIN N, RUBIO, DORIS M · 2016 to 2025
$13.8M
Developing a provider-facing intervention to address cost-related medication restrictions and improve medication use in patients with type 2 diabetesK23DK120956 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LUO, JING · 2021 to 2024
$829k
NCATS NIH HHS KL2 TR001856NCATS NIH HHS UL1 TR001863NIDDK NIH HHS K23 DK120956
6 · The paper itself

Abstract

backgroundMedication price transparency tools are increasingly available, but data on their use, and their potential effects on prescribing behavior, patient out of pocket (OOP) costs, and clinician workflow integration, is limited.

objectiveTo describe the implementation experiences with real-time prescription benefit (RTPB) tools at 5 large academic medical centers and their early impact on prescription ordering.

designand Participants: In this cross-sectional study, we systematically collected information on the characteristics of RTPB tools through discussions with key stakeholders at each of the five organizations. Quantitative encounter data, prescriptions written, and RTPB alerts/estimates and prescription adjustment rates were obtained at each organization in the first three months after "go-live" of the RTPB system(s) between 2019 and 2020. MAIN MEASURES: Implementation characteristics, prescription orders, cost estimate retrieval rates, and prescription adjustment rates. KEY

resultsDifferences were noted with respect to implementation characteristics related to RTPB tools. All of the organizations with the exception of one chose to display OOP cost estimates and suggested alternative prescriptions automatically. Differences were also noted with respect to a patient cost threshold for automatic display. In the first three months after "go-live," RTPB estimate retrieval rates varied greatly across the five organizations, ranging from 8% to 60% of outpatient prescriptions. The prescription adjustment rate was lower, ranging from 0.1% to 4.9% of all prescriptions ordered.

conclusionsIn this study reporting on the early experiences with RTPB tools across five academic medical centers, we found variability in implementation characteristics and population coverage. In addition RTPB estimate retrieval rates were highly variable across the five organizations, while rates of prescription adjustment ranged from low to modest.

Indexed as

Drug CostsDrug PrescriptionsAcademic Medical CentersCross-Sectional StudiesHealth ExpendituresHumans

Identifiers

PMID36989915
PMCPMC10880821

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.